Close this search box.

SIMPLE Study: Impact of Saline Infusion on ME/CFS, POTS and Long COVID

The study will compare the effectiveness of different saline formulations, including a placebo, in individuals with ME/CFS, Long COVID, and POTS, to determine the most beneficial types and understand their impact on patient improvement.

  • David Fineberg, MBBS, FRACGP, DCH
  • Elena Schneider-Futschik, PhD
  • Kristin Brown, PhD
  • Christopher Armstrong, PhD
  • The most commonly reported treatment that improves ME/CFS is IV saline.
  • Intervention trial where patients will each be provided with a mock saline infusion, a saline infusion, saline with dextrose infusion and a Hartmann’s solution.
  • This will form the basis for future trials to be used in conjunction with saline.
  • Recruitment to begin later 2024.
  • Submitted mechanistic paper on Metformin for ME/CFS and LC.

Several trial treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) have utilised saline, with the placebo within those trials also being saline. Consequently, these placebos have shown high improvement levels, suggesting a significant placebo effect. Additionally, many patients, including those with ME/CFS, Long COVID, and Postural Orthostatic Tachycardia Syndrome (POTS), respond positively to saline infusion. Therefore, investigating the impact of saline on these conditions is valuable.

Saline’s rapid improvement in these patients allows for the observation of objective measures of improvement within a short timeframe. This study proposes to trial different saline formulations, including a placebo sham saline, saline alone, saline with dextrose, and Hartmann’s solution, in the same individuals. By comparing their effectiveness beyond placebo, we aim to understand which types of saline or treatments are most beneficial for individuals and why.

Detailing the impact of saline infusion can elucidate its efficacy, identify patient populations most likely to benefit, and characterise its effects for future trials involving saline. This study has the potential to inform clinical practice and improve treatment strategies for individuals with ME/CFS, Long COVID, and POTS.


  1. Assess impact of volume expansion in ME/CFS and LC.
  2. Assess outcome markers against the rapid improvement in symptoms experienced from saline solution.
  3. Determine which type of saline is most effective.
  4. Match effective saline to patient using data collected prior to infusions.

OMF Australia accepts donations of Cryptocurrencies

Make the most of your donation by donating your Bitcoin, Ethereum, and other cryptocurrencies directly to OMF Australia rather than selling and donating the after-tax proceeds.

  • Your tax deduction will be equal to the fair market value of the donated cryptocurrency (as determined by a qualified appraisal).
  • Donors should consult with a tax advisor for properly recording this donation on a personal tax return.

OMF Australia can accept cryptocurrency donations of any amount. 

Donating cryptocurrency is a non-taxable event, meaning you do not owe capital gains tax on the appreciated amount and can deduct it on your taxes. This makes Bitcoin and other cryptocurrency donations one of the most tax-efficient ways to support your favorite cause. If you want to learn more about how donating crypto can lower your taxes, check out

Talk to a crypto-savvy tax professional or connect with The Giving Block to get connected with one.

We accept the following cryptocurrencies: Bitcoin (BTC), Ether (ETH), Litecoin (LTC), Bitcoin Cash (BCH), Zcash (ZEC), Gemini Dollar (GUSD), Basic Attention Token (BAT), Chainlink (LINK), 0x (ZRX), Storj (STORJ), Dai (DAI), Amp (AMP), The Graph (GRT), UMA (UMA), 1inch (1INCH).

ATO Crypto asset investment & tax